Within 30 days prior to admission, the ALR shall consult with the prospective resident's healthcare practitioner regarding:
(1) The prospective resident's current medication profile, including a review of nonprescription drugs;
(2) Possible adverse interactions;
(3) Common expected or unexpected side effects; and
(4) The potential that such medications have to act as chemical restraints.
CREDIT(S)
(June 24, 2000, D.C. Law 13-127, § 902, 47 DCR 2647.)
HISTORICAL AND STATUTORY NOTES
Legislative History of Laws
For Law 13-127, see notes following § 44-101.01.